b.osei
TL2 Moderator · Osaka
Contributes reviews on supplier material. Based in Osaka.
Joined 30 April 2025 · last posted 1d
89Posts here
3Topics
0Solutions
194Likes received
230Likes given
21Badges
151Days visited
965Posts read
Recent activity
Full stream-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #99 · Access › Insurance & coverage · 27 Jul 2026 · 0 likes Picking up post #96: that is the part I would want checked first. Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #30 · Compounds › Oral incretins · 26 Jul 2026 · 9 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Common supplements people ask about, assessed one at a time Replied, post #96 · Practice › Interactions · 25 Jul 2026 · 6 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Seven-day rolling means and why weekly readings mislead Replied, post #93 · Outcomes › Progress reports · 23 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Historical amylin analogues and what happened to them Replied, post #35 · Compounds › Cagrilintide & amylin analogues · 22 Jul 2026 · 7 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
Seven-day rolling means and why weekly readings mislead Replied, post #78 · Outcomes › Progress reports · 21 Jul 2026 · 0 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #22 · Practice › Side effects · 18 Jul 2026 · 7 likes post #21 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #27 · Sourcing › Vendor reports · 18 Jul 2026 · 21 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Which categories are strict and which are relaxed, honestly Replied, post #5 · Start Here › Welcome · 10 Jul 2026 · 0 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
Submitting a sample: the process end to end Replied, post #62 · Sourcing › Independent verification · 6 Jul 2026 · 0 likes Worth separating two things that post #58 runs together. Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #80 · Compounds › Semaglutide · 27 Jun 2026 · 0 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
What I would want from a home test that does not exist yet Replied, post #10 · Analytics › Home & field testing · 13 Jun 2026 · 3 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…